The preparation of metal–organic frameworks and their biomedical application

Rong Liu,1,2 Tian Yu,1 Zheng Shi,1 Zhiyong Wang3 1School of Medicine and Nursing, Chengdu University, Chengdu, 2Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, 3Paul C. Lauterbur Research Center for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liu R, Yu T, Shi Z, Wang ZY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/2149c7d2512a4e298e917f6371770ea7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Rong Liu,1,2 Tian Yu,1 Zheng Shi,1 Zhiyong Wang3 1School of Medicine and Nursing, Chengdu University, Chengdu, 2Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, 3Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Key Laboratory for MRI, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People’s Republic of China Abstract: The development of a safe and targetable drug carrier is a major challenge. An efficient delivery system should protect cargo from degradation and cleanup, and control of drug release in the target site. Metal–organic frameworks (MOFs), consisting of metal ions and a variety of organic ligands, have been applied for drug delivery due to their distinct structure. In this review, we summarized the synthesis strategies of MOFs, especially emphasizing the methods of pore creation in frameworks, which were based on recent literatures. Subsequently, the controlled size, biocompatibility, drug releasing performances, and imaging of MOFs were discussed, which would pave the road for the application in drug-delivery systems. Keywords: metal-organic frameworks, pore creation, the controlled size, biocompatibility, drug releasing performances, imaging